Marital status, treatment, and survival in patients with glioblastoma multiforme: A population-based study

Cancer

Volumn 104, Issue 9, 2005, Pages 1975-1984

  Chang, Susan M ^a   Barker II, Fred G ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Glioblastoma multiforme; Marital status; Radiation therapy; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN TUMOR; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POPULATION RESEARCH; PRIORITY JOURNAL; SOCIAL ASPECT; SURVIVAL RATE; TUMOR VOLUME;

AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MARITAL STATUS; MIDDLE AGED; POPULATION SURVEILLANCE; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 27244451826     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21399     Document Type: Article

References (60)

1. Laws ER, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003;99:467-473.
2. Fiveash JB, Spencer SA. Role of radiation therapy and radiosurgery in glioblastoma multiforme. Cancer J. 2003;9:222-229.
3. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011-1018.
4. Haynes MA, Smedley BD, editors. The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. Washington, DC: National Academy Press, 1999.
5. Kravdal O. Social inequalities in cancer survival. Popul Stud (Camb). 2000;54:1-18.
6. Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA. 1987;258:3125-3130.
7. Kravdal O. The impact of marital status on cancer survival. Soc Sci Med. 2001;52:357-368.
8. Silliman RA, Troyan SL, Guadagnoli E, Kaplan SH, Greenfield S. The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer. 1997;80:1326-1334.
9. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer. 2001;37:332-339.
10. Potosky AL, Saxman S, Wallace RB, Lynch CF. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol. 2004;22:3261-3268.
11. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20: 1192-1202.
12. Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003;21:3488-3494.
13. Lai H, Lai S, Krongrad A, Trapido E, Page JB, McCoy CB. The effect of marital status on survival in late-stage cancer patients: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, in the United States. Int J Behav Med. 1999;6:150-176.
14. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg. 1998;88:1-10.
15. Barnholtz-Sloan JS, Sloan AE, Schwartz AG. Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer. 2003;98:603609.
16. National Cancer Institute. SEER program code manual, 3rd edition. Bethesda, MD: National Cancer Institute, 1998. Available at URL: www.census.gov/hhes/www/saipe/tech-doc/1993/93statemod.html [accessed August 13, 2005].
17. Fritz A, Percy C, Jack A, et al., editors. International classification of diseases for oncology, 3rd edition. Geneva: World Health Organization, 2000.
18. U.S. Census Bureau. Small Area Income and Poverty Estimates, 1993. Washington, DC: U.S. Census Bureau, Year. Available at URL: http://www.census. gov/hhes/www/saipe/ estimatetoc.html [accessed August 13, 2005].
19. Venables WN, Ripley BD. Modern applied statistics with S-Plus, 4th ed. New York: Springer-Verlag, 2002.
20. Harrell FE, Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer, 2001.
21. Harrell FE, Jr. Hmisc and Design libraries for S-Plus for Windows. 2000:Software and electronic documentation available at URL: http://biostat.mc.vanderbilt.edu/twiki/ bin/view/Main/RS [accessed August 13, 2005].
22. Loader C. Local regression and likelihood. New York: Springer-Verlag, 1999.
23. Loader CR. LOCFIT for S-Plus (software and electronic documentation). Murray Hill, NJ: Lucent Technologies, 1998.
24. Ortmeyer CE. Variations in mortality, morbidity, and health care by marital status. In: Ehart CL, Berlin JE, editors. Mortality and morbidity in the United States. Cambridge, MA: Harvard University Press, 1974.
25. Johnson NJ, Backlund E, Sorlie PD, Loveless CA. Marital status and mortality: the national longitudinal mortality study. Ann Epidemiol. 2000;10:224-238.
26. Murray JE. Marital protection and marital selection: evidence from a historical-prospective sample of American men. Demography. 2000;37:511-521.
27. Cheung YB. Can marital selection explain the differences in health between married and divorced people? From a longitudinal study of a British birth cohort. Public Health. 1998; 112:113-117.
28. Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med. 1985;312:1551-1555.
29. Nayeri K, Pitaro G, Feldman JG. Marital status and stage at diagnosis in cancer. N Y State J Med. 1992;92:8-11.
30. Rippentrop JM, Joslyn SA, Konety BR. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer. 2004;101: 1357-1363.
31. Sehlen S, Lenk M, Hollenhorst H, et al. Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy. Onkologie. 2003;26:38-43.
32. Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol. 1988;6:338-343.
33. Curran WJ Jr., Scott CB, Weinstein AS, et al. Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol. 1993;11:857-862.
34. Iwashyna TJ, Christakis NA. Marriage, widowhood, and health-care use. Soc Sci Med. 2003;57:2137-2147.
35. Taplin SH, Ichikawa L, Yood MU, et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst. 2004;96:1518-1527.
36. Inskip PD, Tarone RE, Hatch EE, et al. Sociodemographic indicators and risk of brain tumours. Int J Epidemiol. 2003; 32:225-233.
37. del Aguila MA, Longstreth WT Jr., McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60:813-819.
38. Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E. A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001;51:100-107.
39. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(8 Suppl):IV-43-IV-48.
40. McAleese JJ, Stenning SP, Ashley S, et al. Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother Oncol. 2003;67:177-182.
41. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol. 2004;22:1583-1588.
42. Wellisch DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J. Predicting major depression in brain tumor patients. Psychooncology. 2002;11:230-238.
43. Giovagnoli AR, Silvani A, Colombo E, Boiardi A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry. 2005;76: 562-568.
44. Waxler-Morrison N, Hislop TG, Mears B, Kan L. Effects of social relationships on survival for women with breast cancer: a prospective study. Soc Sci Med. 1991;33:177-183.
45. Barker FG 2nd, Chang SM, Gutin PH, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery. 1998;42:709-723.
46. Castillo MS, Davis FG, Surawicz T, et al. Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems. Neuroepidemiology 2004;23:85-93.
47. Aldape K, Simmons ML, Davis RL, et al. Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer. 2000;88:2342-2349.
48. Scott CB, Nelson JS, Farnan NC, et al. Central pathology review in clinical trials for patients with malignant glioma. A report of Radiation Therapy Oncology Group 83-02. Cancer. 1995;76:307-313.
49. Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care. 2002;40(8 Suppl):IV-49-IV-54.
50. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996;88:716-726.
51. Greenberg ER, Dain B, Freeman D, Yates J, Korson R. Referral of lung cancer patients to university hospital cancer centers. A population-based study in two rural states. Cancer. 1988;62:1647-1652.
52. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1987;8(4 Suppl):6S-30S.
53. Hunter CP, Frelick RW, Feldman AR, et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treat Rep. 1987;71:559-565.
54. Yeomans-Kinney A, Vernon SW, Frankowski RF, Weber DM, Bitsura JM, Vogel VG. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer. 1995;76: 46-56.
55. DeLuca SA, Korcuska LA, Oberstar BH, Rosenthal ML, Welsh PA, Topol EJ. Are we promoting true informed consent in cardiovascular clinical trials? J Cardiovasc Nurs. 1995;9:54-61.
56. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995;87:1747-1759.
57. Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL. Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control Clin Trials. 1997; 18:328-352.
58. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52:1143-1156.
59. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
60. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720-2726.